| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Potential biomarker for PD; associated with symptom severity measures (UPDRS-III; MoCA). |
| Molecular mechanism: |
Predicted miRNA targeting (in-silico) with circRNA-miRNA correlations; downstream pathway enrichment via miRNAs. |
| Biological pathway or process: |
Hippo/YAP (other); other pathway/process (other) |
| Detected method: |
S
|
| Validation methods: |
RNA-seq; Bioinformatics Analysis; ROC Analysis |
| Clinical significance: |
Associated with PD and evaluated as part of circRNA biomarkers; circAFF2 correlated with UPDRS-III and MoCA. |
| Description: |
circAFF2 is differentially accumulated (up-regulated) in PD blood in cross-sectional analyses and is one of five high-confidence circRNAs highlighted by the study. It shows significant correlations with motor severity (UPDRS-III) and cognitive score (MoCA) and is evaluated as part of circRNA biomarker efforts. |
| Confidence score: |
0.348 |